<p>d. In children with autoinflammatory disorders or systemic juvenile idiopathic arthritis in whom the risk of disease flare if biologic DMARDs are held is very high, shorter hold times can be considered if live-attenuated vaccination is critical.</p>

<p>e. the recommendation to hold IVIG prior to vaccination is designed to enhance vaccine efficacy, not safety. In some situations, such as during a measles outbreak, earlier vaccination would be preferred over delay.</p>

<h1>When to administer live-attenuated rotavirus vaccination to infants exposed to immunosuppressive medications in utero</h1>

<p>|Antenatal drug exposure in second or third trimester|Within the first 6 months of life|After 6 months of life|
|---|---|---|
|TNF inhibitor|Give rotavirus vaccine| |
|Rituximab|Do not give rotavirus vaccine|Give rotavirus vaccine|</p>